Frank Mottola is SVP, Quality, GMP, Ops, IT of SUPERNUS PHARMACEUTICALS, INC.. Currently has a direct ownership of 8,200 shares of SUPN, which is worth approximately $300,202. The most recent transaction as insider was on Nov 07, 2024, when has been sold 15,000 shares (Common Stock) at a price of $36.98 per share, resulting in proceeds of $554,700. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 8.2K
5.41% 3M change
73.11% 12M change
Total Value Held $300,202

Frank Mottola Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 07 2024
SELL
Open market or private sale
$554,700 $36.98 p/Share
15,000 Reduced 64.66%
8,200 Common Stock
Nov 07 2024
BUY
Exercise of conversion of derivative security
$136,950 $9.13 p/Share
15,000 Added 39.27%
23,200 Common Stock
Feb 28 2024
SELL
Payment of exercise price or tax liability
$12,852 $27.94 p/Share
460 Reduced 5.58%
7,779 Common Stock
Feb 28 2024
BUY
Exercise of conversion of derivative security
-
990 Added 10.73%
8,239 Common Stock
Feb 23 2024
SELL
Payment of exercise price or tax liability
$27,229 $29.06 p/Share
937 Reduced 11.45%
7,249 Common Stock
Feb 23 2024
BUY
Grant, award, or other acquisition
-
1,875 Added 18.64%
8,186 Common Stock
Feb 22 2024
SELL
Payment of exercise price or tax liability
$9,359 $27.94 p/Share
335 Reduced 5.04%
6,311 Common Stock
Feb 22 2024
BUY
Grant, award, or other acquisition
-
750 Added 10.14%
6,646 Common Stock
Nov 14 2023
SELL
Open market or private sale
$31,224 $28.13 p/Share
1,110 Reduced 16.35%
5,681 Common Stock
Nov 14 2023
BUY
Exercise of conversion of derivative security
$18,480 $9.24 p/Share
2,000 Added 22.75%
6,791 Common Stock
Mar 14 2023
SELL
Open market or private sale
$172,032 $35.99 p/Share
4,780 Reduced 50.23%
4,737 Common Stock
Feb 22 2023
BUY
Grant, award, or other acquisition
-
750 Added 7.3%
9,517 Common Stock
Feb 16 2023
SELL
Payment of exercise price or tax liability
$29,171 $38.74 p/Share
753 Reduced 8.42%
8,191 Common Stock
Feb 16 2023
BUY
Exercise of conversion of derivative security
-
1,500 Added 14.36%
8,944 Common Stock
FM

Frank Mottola

SVP, Quality, GMP, Ops, IT
Rockville, MD

Track Institutional and Insider Activities on SUPN

Follow SUPERNUS PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SUPN shares.

Notify only if

Insider Trading

Get notified when an Supernus Pharmaceuticals, Inc. insider buys or sells SUPN shares.

Notify only if

News

Receive news related to SUPERNUS PHARMACEUTICALS, INC.

Track Activities on SUPN